- Capital Cube•2 months ago
Click here to see latest analysisCesca Therapeutics, Inc. reports financial results for the quarter ended March 31, 2016.We analyze the earnings along side the following peers of Cesca Therapeutics, Inc. – Cerus Corporation, Stryker Corporation, Haemonetics Corporation, Cytori Therapeutics, Inc. and Span-America Medical Systems, Inc. (CERS-US, SYK-US, HAE-US, CYTX-US and SPAN-US) that have also reported […] (Read more...) The post Cesca Therapeutics, Inc. :KOOL-US: Earnings Analysis: Q3, 2016 By the Numbers appeared first on CapitalCube.
Cesca Therapeutics Inc.NasdaqCM
After hours: 4.480.08 (1.82%) as of 6:58 PM EDT
|Bid||4.40 x 300|
|Ask||4.48 x 800|
|52wk Range||1.60 - 15.40|
|Day's Range||4.20 - 5.59|
|Avg Vol (3m)||505,860|
As of 4:00 PM EDT. Market closed.